I-FDA-approved:
1-Ledipasvir, fixed-dose combination (FDC) with sofosbuvir
2-Ombitasvir, with paritaprevir and ritonavir, co-packaged with dasabuvir
3-Daclatasvir
4-Elbasvir, with grazoprevir
5-Velpatasvir, with sofosbuvir and voxilaprevir
6-Pibrentasvir, with glecaprevir
II-Investigational drugs:
1-Odalasvir
2-Ravidasvir
3-Ruzasvir
4-Samatasvir